Physician profile
Anne Didier
NPI 1427696855
$1,260.50
in general payments reported to CMS, 2019-2025
14 companies · none reported in 2025
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $1,059 · 2023: $20.90 · 2024: $180.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $201.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $201.38 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Genentech USA, INC. | $336.44 | 2021 | |
| Seagen INC. | $264.03 | 2021 | |
| Adc Therapeutics America, INC. | $215.98 | 2021-2024 | |
| Coherus Oncology, INC. | $118.41 | 2021 | |
| Puma Biotechnology, INC. | $76.71 | 2024 | |
| Gilead Sciences, INC. | $45.02 | 2021 | |
| Novartis Pharmaceuticals Corporation | $42.44 | 2021 | |
| Ipsen Biopharmaceuticals, INC | $35.44 | 2021 | |
| Lilly USA, LLC | $26.72 | 2021 | |
| Daiichi Sankyo INC. | $24.73 | 2021 | |
| Abbvie INC. | $20.90 | 2023 | |
| Janssen Biotech, INC. | $19.54 | 2021 | |
| Array Biopharma INC | $18.02 | 2021 | |
| Amag Pharmaceuticals, INC. | $16.12 | 2021 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Anne Didier listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.